NINGBO INNO PHARMCHEM CO.,LTD. is a leading supplier of high-grade chemical compounds, with a significant emphasis on pharmaceutical intermediates like Procaine Base Powder. This compound, identified by its CAS number 59-46-1, is a cornerstone in the development of various pharmaceutical products, primarily recognized for its anesthetic capabilities.

The critical nature of pharmaceutical manufacturing demands ingredients of the highest purity and consistent quality. Our 99% purity procaine base powder is meticulously produced and tested to meet rigorous international standards, including USP, BP, EP, and CP. This ensures that every batch delivered by NINGBO INNO PHARMCHEM CO.,LTD. contributes to the safety and effectiveness of the final pharmaceutical product. Whether used as a local anesthetic, analgesic, or for its anti-inflammatory properties, the integrity of the procaine is paramount.

Understanding the global nature of the pharmaceutical supply chain, NINGBO INNO PHARMCHEM CO.,LTD. prioritizes logistical excellence. We offer safe DDP shipping procaine to a wide array of international destinations. This service simplifies the procurement process for our clients by managing all shipping and customs complexities, ensuring that the essential pharmaceutical intermediate procaine arrives on time and in perfect condition.

The chemical properties of procaine CAS 59-46-1 USP BP EP CP make it an indispensable component in many formulations. Its ability to block nerve impulses effectively makes it a preferred choice for pain management and local anesthesia. The consistent supply of such vital materials is a testament to NINGBO INNO PHARMCHEM CO.,LTD.'s commitment to supporting the global healthcare industry.

For businesses seeking a reliable and high-quality source for Procaine Base Powder, NINGBO INNO PHARMCHEM CO.,LTD. provides an unparalleled offering. Our dedication to purity, adherence to pharmaceutical standards, and robust global logistics network make us the partner of choice for ensuring the efficacy and availability of critical pharmaceutical ingredients.